Chinese vaccines set to swarm developing world


Global recognition: Two Chinese vaccines are being used by many countries now – CoronaVac (left) and the WHO-listed Sinopharm vaccine (right).

With the world facing acute shortage in Covid-19 vaccines, WHO’s nod for global use of China’s Sinopharm vaccine provides a huge relief.

IN recent weeks, there has been an incessant flow of exciting news on Chinese vaccines that carries wide-ranging implications for China as well as vaccine-deprived developing countries.

On May 7, the World Health Organisation announced its approval for emergency use a Covid-19 vaccine from China’s government-owned drugmaker Sinopharm, greenlighting it to be rolled out globally.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Covid-19 vaccines , WHO , China , Sinopharm vaccine ,

   

Next In Columnists

Tragedy returns to haunt politicians
The Charity Shield axe – a tragedy or an opportunity missed
Changing habits worth the payoff
Never-ending battle against graft
The Premiership run-in - a football saga of glory and drama
Why do we let others measure us?
Empowering Futures: Malaysia-China GDI collaboration for human capital growth
‘Twisted’ fate of manhood
The Indian factor
Not worth the gamble

Others Also Read